Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Enrique Álvarez, MD, PhD
JCP
Original Research
Early Response and Remission as Predictors of a Good Outcome of a Major Depressive Episode at 12-Month Follow-Up: A Prospective, Longitudinal, Observational Study
October 4, 2011
Antonio Ciudad
,
Enrique Álvarez
,
Miquel Roca
, et al
JCP
Original Research
Ziprasidone in the Treatment of Borderline Personality Disorder: A Double-Blind, Placebo-Controlled, Randomized Study
March 18, 2008
Enrique Álvarez
,
Dolors Puigdemont
,
Joaquim Soler
, et al
JCP
Letter to the Editor
Ziprasidone in the Acute Treatment of Borderline Personality Disorder in Psychiatric Emergency Services
September 1, 2004
Enrique Álvarez
,
Sílvia Oller
,
Víctor Pérez
, et al
JCP
Original Research
Olanzapine in Treatment-Refractory Schizophrenia: Results of an Open-Label Study
November 15, 1997
Manuel Gurpegui
,
Enrique Álvarez
,
Joaquín Martín
, et al
